Ovid Therapeutics (OVID) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Ovid Therapeutics (OVID) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 73.00% |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - | -52.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.65% |
| Sep 30, 2025 | 87.51% |
| Jun 30, 2025 | -104.83% |
| Mar 31, 2025 | -12.37% |
| Dec 31, 2024 | 96.57% |
| Sep 30, 2024 | -953.53% |
| Jun 30, 2024 | 58.56% |
| Mar 31, 2024 | 29.64% |
| Dec 31, 2023 | 98.22% |
| Sep 30, 2023 | 90.19% |
| Jun 30, 2023 | 60.80% |
| Mar 31, 2023 | -21.69% |
| Dec 31, 2022 | -1,675.96% |
| Sep 30, 2022 | -42.35% |
| Jun 30, 2022 | -144.62% |
| Mar 31, 2022 | -119.31% |
| Dec 31, 2021 | 66.68% |
| Sep 30, 2021 | -147.76% |
| Jun 30, 2021 | -98.73% |
| Mar 31, 2021 | 372.13% |